Australia markets closed

Tonix Pharmaceuticals Holding Corp. (TPM0.F)

Frankfurt - Frankfurt Delayed price. Currency in USD
Add to watchlist
0.0000-2.8200 (-100.00%)
At close: 08:25AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
7,768
0
0
0
Cost of revenue
4,741
4,741
0
-
-
Gross profit
3,027
3,027
0
-
-
Operating expenses
Research development
79,498
86,655
81,876
68,838
36,157
Selling general and administrative
29,344
34,752
30,215
23,474
14,354
Total operating expenses
108,842
121,407
112,091
92,312
50,511
Operating income or loss
-108,842
-118,380
-112,091
-92,312
-50,511
Total other income/expenses net
1,722
1,722
1,873
-
-
Income before tax
-108,091
-116,658
-110,218
-92,287
-50,463
Income from continuing operations
-108,091
-116,658
-110,218
-92,287
-50,463
Net income
-108,091
-116,658
-110,218
-92,287
-50,463
Net income available to common shareholders
-112,346
-116,658
-116,877
-92,287
-52,174
Basic EPS
-9.26
-
-20.44
-50.62
-110.00
Diluted EPS
-9.26
-
-20.44
-50.62
-110.00
Basic average shares
11,436
-
5,718
1,822
472.958
Diluted average shares
11,436
-
5,718
1,822
472.958